Skip to main content
Erschienen in: Indian Journal of Gastroenterology 1/2011

01.02.2011 | Original Article

Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication

verfasst von: Avinash Agrawal, Alok Gupta, Mam Chandra, Sciddhartha Koowar

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Background and Aim

Helicobacter pylori (H. pylori) bacteria convert urea to ammonia, which has been implicated in causation of hepatic encephalopathy in patients with liver cirrhosis. The role of H. pylori infection in causation of minimal hepatic encephalopathy (MHE) has not been well studied. We looked at the relationship of H. pylori infection with MHE and hyperammonemia in patients with liver cirrhosis and the effects of anti-H. pylori treatment in patients with MHE and H. pylori infection.

Methods

Patients with liver cirrhosis underwent psychometric tests for detection of MHE, rapid urease test to look for evidence of H. pylori infection and measurement of fasting blood ammonia levels. Patients with MHE were treated with triple-drug anti-H. pylori treatment for one week. Rapid urease test, blood ammonia levels, and psychometric tests were repeated four weeks after treatment.

Results

H. pylori infection was found more often in patients with MHE (63%) than in those without MHE (37%). Blood ammonia levels were significantly higher in patients with MHE than those without. After H. pylori treatment in patients with MHE, blood ammonia levels showed a significant decline and psychometric test results returned towards normal.

Conclusion

In patients with liver cirrhosis, there is a significant association between H. pylori infection and MHE. Anti-H. pylori therapy results in reduction in blood ammonia levels and improvement in MHE.
Literatur
1.
Zurück zum Zitat Mullen KD, Dasarthy S. Hepatic Encephalopathy. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff’s Disease of the Liver. 8th ed. Philadelphia: Lippincott-Raven; 1990. p. 545–81. Mullen KD, Dasarthy S. Hepatic Encephalopathy. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff’s Disease of the Liver. 8th ed. Philadelphia: Lippincott-Raven; 1990. p. 545–81.
2.
Zurück zum Zitat Butterworth RF. Complications of cirrhosis III: Hepatic Encephalopathy. J Hepatol. 2000;32 Suppl 1:171–86.PubMedCrossRef Butterworth RF. Complications of cirrhosis III: Hepatic Encephalopathy. J Hepatol. 2000;32 Suppl 1:171–86.PubMedCrossRef
3.
4.
Zurück zum Zitat Dhiman RK, Saraswat VA, Verma M, et al. Figure connection test: a universal test for assessment of mental state. J Gastroenterol Hepatol. 1995;10:726–31.CrossRef Dhiman RK, Saraswat VA, Verma M, et al. Figure connection test: a universal test for assessment of mental state. J Gastroenterol Hepatol. 1995;10:726–31.CrossRef
5.
Zurück zum Zitat Gubbins GP, Moritz TE, Marsano LS, et al. The Veterans Administration Cooperative Study Group No. 275. Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: The ammonia hypothesis revised. Am J Gastroenterol. 1993;88:1907–9. Gubbins GP, Moritz TE, Marsano LS, et al. The Veterans Administration Cooperative Study Group No. 275. Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: The ammonia hypothesis revised. Am J Gastroenterol. 1993;88:1907–9.
6.
Zurück zum Zitat Miyaji H, Ito S, Azuma T, et al. Effect of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis. Gut. 1997;40:726–30.PubMedCrossRef Miyaji H, Ito S, Azuma T, et al. Effect of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis. Gut. 1997;40:726–30.PubMedCrossRef
7.
Zurück zum Zitat Ito S, Miyaji H, Azuma T, et al. Hyperammonaemia and Helicobacter pylori. Lancet. 1995;346:124–5.PubMedCrossRef Ito S, Miyaji H, Azuma T, et al. Hyperammonaemia and Helicobacter pylori. Lancet. 1995;346:124–5.PubMedCrossRef
8.
Zurück zum Zitat Quero JC, Hartmann IJC, De Rooij F, et al. Hyperammonamia and Helicobacter pylori. Lancet. 1995;346:713–4.PubMedCrossRef Quero JC, Hartmann IJC, De Rooij F, et al. Hyperammonamia and Helicobacter pylori. Lancet. 1995;346:713–4.PubMedCrossRef
9.
Zurück zum Zitat Plevris JN, Morgenstern R, Hayes PC, Bouchier IAD. Hyperammonaemia in cirrhosis and Helicobacter pylori infection. Lancet. 1995;346:1104.PubMedCrossRef Plevris JN, Morgenstern R, Hayes PC, Bouchier IAD. Hyperammonaemia in cirrhosis and Helicobacter pylori infection. Lancet. 1995;346:1104.PubMedCrossRef
10.
Zurück zum Zitat Mousseau DD, Butterworth RF. Current theories on the pathogenesis of hepatic encephalopathy. Proc Soc Exp Biol Medi. 1994;206:329–44. Mousseau DD, Butterworth RF. Current theories on the pathogenesis of hepatic encephalopathy. Proc Soc Exp Biol Medi. 1994;206:329–44.
11.
Zurück zum Zitat Rilandi V, Zullo A, Diana F, Capocaccia L. Helicobacter pylori, Hyperammonemia and hepatic encephalopathy: is there a correlation? Am J Gastroenterol. 1997;92:723–34. Rilandi V, Zullo A, Diana F, Capocaccia L. Helicobacter pylori, Hyperammonemia and hepatic encephalopathy: is there a correlation? Am J Gastroenterol. 1997;92:723–34.
12.
Zurück zum Zitat Vásconez C, Elizalde JI, Llach J, et al. Helicobacter pylori hyperammonemia and subclinical portosystemic encephalopathy: Effects of eradication. J Hepatol. 1999;30:260–4.PubMedCrossRef Vásconez C, Elizalde JI, Llach J, et al. Helicobacter pylori hyperammonemia and subclinical portosystemic encephalopathy: Effects of eradication. J Hepatol. 1999;30:260–4.PubMedCrossRef
13.
Zurück zum Zitat Quero JC, Hartmenn IJ, De Rooij F, Wilson JH, Schalm SW. Hyperammonaemia and Helicobacter pylori. Lancet. 1995;346:713–4.PubMedCrossRef Quero JC, Hartmenn IJ, De Rooij F, Wilson JH, Schalm SW. Hyperammonaemia and Helicobacter pylori. Lancet. 1995;346:713–4.PubMedCrossRef
14.
Zurück zum Zitat Calvet X, Navarro M, Gill M, et al. Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis. J Hepatol. 1997;26:1249–54.PubMedCrossRef Calvet X, Navarro M, Gill M, et al. Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis. J Hepatol. 1997;26:1249–54.PubMedCrossRef
15.
Zurück zum Zitat Rossle M, Haag K, Ochs A. et al. Helicobacter pylori infection is not associated with an increased risk of hepatic encephalopathy (abstract). Hepatology. 1994;20:111A.CrossRef Rossle M, Haag K, Ochs A. et al. Helicobacter pylori infection is not associated with an increased risk of hepatic encephalopathy (abstract). Hepatology. 1994;20:111A.CrossRef
16.
Zurück zum Zitat Huber M, Rössle M, Siegerstetter V, et al. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis Hepatogastroenterology. 2001;48:541–4.PubMed Huber M, Rössle M, Siegerstetter V, et al. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis Hepatogastroenterology. 2001;48:541–4.PubMed
17.
Zurück zum Zitat Watanabe A, Sakai T, Sato S, et al. Clinical efficacy of Lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology. 1997;26:1410–4.PubMedCrossRef Watanabe A, Sakai T, Sato S, et al. Clinical efficacy of Lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology. 1997;26:1410–4.PubMedCrossRef
Metadaten
Titel
Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication
verfasst von
Avinash Agrawal
Alok Gupta
Mam Chandra
Sciddhartha Koowar
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 1/2011
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-011-0087-7

Weitere Artikel der Ausgabe 1/2011

Indian Journal of Gastroenterology 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.